Form Health vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 36)
Form Health logo

Form Health

EmergingHealthTech

Virtual Weight Management

Virtual obesity medicine practice with board-certified physicians, dietitians, and coaches; treats obesity as a chronic disease using GLP-1 medications with individualized behavioral plans.

AI VisibilityBeta
Overall Score
D36
Category Rank
#530 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
41
Perplexity
33
Gemini
38

About

Form Health is a virtual obesity medicine practice that delivers medically supervised weight loss care through a team-based model pairing board-certified obesity medicine physicians with registered dietitians and health coaches, all accessible through a telehealth platform. The practice treats obesity as a complex chronic disease and develops individualized treatment plans that may include anti-obesity medications — including GLP-1 receptor agonists like semaglutide and tirzepatide — alongside nutritional counseling, behavioral health support, and physical activity guidance based on each patient's medical history, comorbidities, and treatment goals. This multidisciplinary approach mirrors the clinical model of a hospital-based obesity medicine program delivered through a scalable virtual format.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

36
Overall Score
93
#530
Category Rank
#1
72
AI Consensus
80
stable
Trend
stable
41
ChatGPT
94
33
Perplexity
89
38
Gemini
94
31
Claude
92
41
Grok
98

Key Details

Category
Virtual Weight Management
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Form Health
Virtual Weight Management

Integrations

Only Pfizer
Pfizer is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.